Aurelius Value

Latest articles

8d
Business Wire
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in PetMed Express, Inc. of Class Action Lawsuit and Upcoming Deadline – PETSthe foregoing, PetMed’s public statements were materially false and misleading
Business Wire / Posted 8 days ago
the foregoing, PetMed’s public statements were materially false and misleading at all relevant times. On August 23, 2017, Aurelius Value published a report entitled “PetMed: Exploiting America’s Opioid Epidemic,” alleging that the Company targets... Read more
2 related articles
12d
Business Wire
Law Offices of Howard G. Smith Continues Investigation on Behalf of PetMed Express, Inc. InvestorsOn August 23, 2017, Aurelius Value published a report alleging that the Company
Business Wire / Posted 12 days ago
On August 23, 2017, Aurelius Value published a report alleging that the Company targets opioid users with Google ads and other marketing techniques to facilitate the abuse of opiates. On this news the Company’s stock dropped $0.26 on August 24, 2017... Read more
9 related articles
16d
Business Wire
PETMED SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against PetMed Express, Inc. - (PETS)Period, violating federal securities laws. On August 23, 2017, it was revealed
Business Wire / Posted 16 days ago
Period, violating federal securities laws. On August 23, 2017, it was revealed through a comprehensive report issued by Aurelius Value entitled “PetMed: Exploiting America’s Opioid Epidemic” that PetMed Express had targeted its products,... Read more
18d
Business Wire
Glancy Prongay & Murray LLP Continues Investigation on Behalf of PetMed Express, Inc. Investors (PETS)On August 23, 2017, Aurelius Value published a report alleging that the Company
Business Wire / Posted 18 days ago
On August 23, 2017, Aurelius Value published a report alleging that the Company targets opioid users with Google ads and other marketing techniques to facilitate the abuse of opiates. On this news, shares of PETMED stock dropped $3.19 per share, or... Read more
23d
Business Wire
PETMED SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against PetMed Express, Inc. - (PETS)Period, violating federal securities laws. On August 23, 2017, it was revealed
Business Wire / Posted 23 days ago
Period, violating federal securities laws. On August 23, 2017, it was revealed through a comprehensive report issued by Aurelius Value entitled “PetMed: Exploiting America’s Opioid Epidemic” that PetMed Express had targeted its products,... Read more
10 related articles
23d
Business Wire
Goldberg Law PC Announces an Investigation of MiMedx Group, Inc.on whether MiMedx and certain of its officers and/or directors violated federal
Business Wire / Posted 23 days ago
on whether MiMedx and certain of its officers and/or directors violated federal securities laws. On September 20, 2017, Aurelius Value published a report questioning whether the Company engaged in improper “channel stuffing” in violation of... Read more
23d
Business Wire
Robbins Arroyo LLP Is Investigating the Officers and Directors of MiMedx Group, Inc. (MDXG) on Behalf of Shareholdersthe Focus of an Investigation by the U.S. Securities and Exchange Commission O
Business Wire / Posted 23 days ago
the Focus of an Investigation by the U.S. Securities and Exchange Commission On September 20, 2017, market research group Aurelius Value issued a report alleging that MiMedx may be under investigation by the U.S. Securities and Exchange Commission... Read more
27d
Business Wire
Bragar Eagel & Squire, P.C. is Investigating MiMedx Group, Inc. (MDXG) on Behalf of Stockholders and Encourages Investors to Contact the Firmsecurities laws and/or engaged in other unlawful business practices. On Septem
Business Wire / Posted 27 days ago
securities laws and/or engaged in other unlawful business practices. On September 20, 2017, the market research groups Aurelius Value and Viceroy Research published reports alleging that MiMedx may be under investigation by the SEC. The... Read more

In this news